Your session is about to expire
← Back to Search
Airway Clearance Device
OPEP group for Bronchiectasis
N/A
Waitlist Available
Led By Mark Jennings, MD
Research Sponsored by Hill-Rom
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Radiological diagnosis of Bronchiectasis based on high resolution chest CT scan
History of at least 2 acute exacerbations or hospitalizations in the past 12 months
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights
Study Summary
This trial will compare two treatments for bronchiectasis not caused by cystic fibrosis: OPEP and HFCWO.
Eligible Conditions
- Bronchiectasis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Frequency of acute exacerbations of bronchiectasis
Secondary outcome measures
6-minute walk test
Inflammation - measured by sputum neutrophil elastase level
Mean adherence to prescribed treatment regimen
+10 moreTrial Design
2Treatment groups
Active Control
Group I: OPEP groupActive Control1 Intervention
Subjects in this arm of treatment will use the Acapella® as their primary airway clearance modality for the duration of the study.
Group II: HFCWO groupActive Control1 Intervention
Subjects in this arm of treatment will use The Vest® as their primary airway clearance modality for the duration of the study.
Find a Location
Who is running the clinical trial?
Hill-RomLead Sponsor
33 Previous Clinical Trials
2,799 Total Patients Enrolled
1 Trials studying Bronchiectasis
Mark Jennings, MDPrincipal InvestigatorJohns Hopkins University
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger